Though the level of equine-IL-10 transcript was not significant in the ciliary body of the low dose group, clinically this group effectively reduced EAU clinical symptoms, suggesting that even very low levels of AAV-Equine-IL10 may suppress uveitis symptoms. This evidence concerns the gene IL10 and uveitis.